London, UK; Brentwood, TN, US; 14 February 2008 - Protherics PLC (“Protherics” or the “Company”), the international biopharmaceutical company focused on critical care and cancer, today provides its Interim Management Statement for the quarter ended 31 December 2007. Highlights since 1 October 2007:
